Abstract:Objective: To explore the rule of proliferation of T lymphocyte subsets in patients with clinical asthma remission and the molecular mechanism. Methods: Peripheral blood samples were collected from 15 asthmatic patients, 15 asthmatic patients in clinical remission, and 15 healthy control subjects, all sex-, and age-matched. CD(4)(+) T and CD(8)(+) T lymphocytes were isolated. Flow cytometry was used to examine the cell cycles of CD(4)(+) T and CD(8)(+) T lymphocytes. Fluorescence immunohistochemistry was used to detect the expression levels of cell cycle regulatory proteins (CCRPs), including cyclin D, cyclin E, and P27(kip1), PI3K, and STAT6. Results: (1) The percentage of G(0)/G(1) phase of the CD(4)(+) T lymphocytes of the asthmatic patients was 82.00%, significantly lower than those of the asthmatic patients in clinical remission and healthy controls (92.50% and 99.00%, Z = 12.35, P < 0.01). The percentage of S phase of the CD(4)(+) T lymphocytes of the asthmatic patients was 18.00%, significantly higher than those of the asthmatic patients in clinical remission and healthy controls (6.10% and 0.20% respectively, Z = 8.05, P < 0.05). The percentage of G(2)/M phase of the CD(4)(+) T lymphocytes of the asthmatic patients was 2.80%, significantly higher than those of the asthmatic patients in clinical remission and healthy controls (0.40% and 0 respectively, Z = 9.16, P < 0.05). The S + G(2)/M phase of the CD(4)(+) T lymphocytes of the asthmatic patients was 18.00%, significantly higher than those of the asthmatic patients in clinical remission and healthy controls (7.50% and 0.20% respectively, Z = 12.80, P < 0.05). The distribution of G(0)/G(1) phase of CD(8)(+) T lymphocyte of the asthmatic patients was 44.60%, significantly lower than those of the asthmatic patients in clinical remission and healthy controls (95.90% and 100.00% respectively, Z = 21.60, P < 0.01). The distribution of S phase of CD(8)(+) T lymphocytes of the asthmatic patients was 51.70%, significantly lower than those of the asthmatic patients in clinical remission and healthy controls (0.80% and 0 respectively, Z = 25.22, P < 0.01). The distribution of S + G(2)/M phase of the CD(8)(+) T lymphocytes of the asthmatic patients was 55.40%, significantly higher than those of the asthmatic patients in clinical remission and healthy controls (4.10% and 0 respectively, Z = 21.52, P < 0.01). (2) The expression level of P27(kipl) of the CD(4)(+) T lymphocytes of the asthmatic patients was 13.20%, significant lower than those of the asthmatic patients in clinical remission and healthy controls (38.80% and 47.20% respectively, Z = 10.63, P < 0.01). The expression level of cyclin D of the CD(4)(+) T lymphocyte of the asthmatic patients was 35.00%, significant higher than those of the asthmatic patients in clinical remission and healthy controls (28.20% and 13.10% respectively, Z = 10.66, P < 0.01). The expression level of cyclin E of the CD(4)(+) T lymphocytes of the asthmatic patients was 7.90%, significant higher than those of the asthmatic patients in clinical remission and healthy controls (6.30% and 3.70% respectively, Z = 6.64%, P < 0.05). The expression level of P27(kipl) of the CD(8)(+) T lymphocyte of the asthmatic patients was 4.50%, significant lower than those of the asthmatic patients in clinical remission and healthy controls (33.80% and 46.30% respectively, Z = 9.30, P < 0.05). The expression level of cyclin D of the CD(8)(+) T lymphocyte of the asthmatic patients was 24.20%, not significant different from those of the asthmatic patients in clinical remission and healthy controls (26.10% and 32.20% respectively, Z = 0.09, P > 0.05). The expression level of cyclin E of the CD(8)(+) T lymphocyte of the asthmatic patients was 9.30%, significant higher than those of the asthmatic patients in clinical remission and healthy controls (5.60% and 3.50% respectively, Z = 4.91, P > 0.05). (3) The expression level of PI(3)K-110alpha of the CD(4)(+) T lymphocyte of the asthmatic patients was 7.60%, significant higher than those of the asthmatic patients in clinical remission and healthy controls (6.40% and 3.30% respectively, Z = 9.04, P < 0.05). The expression level of STST()6 of the CD(4)(+) T lymphocyte of the asthmatic patients was 8.20%, significant higher than those of the asthmatic patients in clinical remission and healthy controls (2.70% and 1.90% respectively, Z = 18.08, P > 0.01). The expression levels of PI(3)K-110alpha and STST(6) of the CD(8)(+) T lymphocytes of the asthmatic patients were not significant different from those of the asthmatic patients in clinical remission and healthy controls (Z = 4.91 and 5.70, both P > 0.05). Conclusion: There is excessive proliferation of CD(4)(+) T lymphocytes in the patients with clinical asthma remission, which may be related to the abnormal expression of CCRP (cyclin D, cyclin E, and P27(kip1)), PI(3)K, and STAT(6).

Expression of GATA3 and PIM2 of Regulatory T Cells in Peripheral Blood of Patients with Asthma and Clinical Significance

The Imbalance of FOXP3/GATA3 in Regulatory T Cells from the Peripheral Blood of Asthmatic Patients

Expressions of T-bet, GATA-3, RORγt and FoxP3 Mrna in Peripheral Blood of Patients with Allergic Asthma

Imbalanced T Cell-Specific Transcription Factors T-bet and GATA-3 Contributes to Type 2 T Helper Cell Polarization in Asthmatic Patients

An increased ratio of Th2/Treg cells in patients with moderate to severe asthma.

Effect of T-regulatory cells on helper T1 and helper T2 cells in asthmatic patients

Significance of T-bet/GATA-3 Ratio in Immune Disbalance of Asthmatic Rats

[Expression of T-bet, GATA-3 and FOXP3 Mrna in Asthmatic Peripheral Blood Mononuclear Cells Stimulated by Dermatophagoides Farinae Antigen].

Regulatory T Cells and Th1/Th2 in Peripheral Blood and Their Roles in Asthmatic Children.

The Expression of IL-4 of Regulatory T Cells in Peripheral Blood of Patients with Allergic Asthma and Its Clinical Significance

[Imbalanced T Cell-Specific Transcription Factors T-bet and GATA-3 and Relationship to Airway Inflammation in Asthmatic Rats].

The Changes of Regulatory T Cells and T Helper Cell in Peripheral Blood and Their Significance in Patients with Asthma

Expression of interleukin-17~+ regulatory T cells in peripheral blood of allergic asthma and its clinical significance

Abnormal suppressive capacity of regulatory T cells to Th17 and Th9 cells in asthmatic patients

Express of TIM-3 and Galectin-9 Genes in Peripheral Blood Mononuclear Cells from Patients with Asthma

Role of Regulatory T Cells with IL-4R Expression in Allergic Asthma

The majority of Role of PIM 2 in allergic asthma

[Proliferation of T lymphocyte subsets in asthma patients in clinical remission and molecular mechanism thereof]

Increases in peripheral SIRT1: A new biological characteristic of asthma.

The Declined CD4+ CD25+Treg Cells in Patients with Moderate to Severe Asthma Associated with Over-Expressed Th2 Response

Analysis of CD4 + CD25 + regulatory T cells and Foxp3 mRNA in the peripheral blood of patients with asthma